Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Regenix Drugs Limited, is an unlisted public company incorporated on 10 May, 2007. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 21.55 cr and the total paid-up capital is INR 18.08 cr.
Regenix Drugs Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 145.08% over the previous year. At the same time, it's book networth has increased by 6.36%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2022 numbers.
39.92%
145.08%
-7.25%
6.36%
-3.98%
5.06%
0.84
2.86
-0.56
-0.88
73.49
-0.04
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(22)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 11.2 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Ramamurthy Ayyavuthevar
Shareholder
|
00446203 | 18 years |
| Director | Gunasekaran Raju
Shareholder
|
01951733 | 17 years |
| Director | Malathi Ramamurthy
Shareholder
|
01965601 | 13 years |
| Director | Govindarajan Venkatakrishna
Shareholder
|
02159359 | 15 years |
| Director | Radhakrishnan Venu Murali | 02285294 | 1 years |
| Director | Arvind Akshay | 05355266 | 2 years |
| Director | Ayyamperumal
Shareholder
|
08545531 | 5 years |
| Kmp | Krishanamoorthy Nirosha | <HIDDEN> | 10 years |
| Whole-time Director | Krishanamoorthy Nirosha | 09056949 | 4 years |
| Director | Guhan Ramamurthy
Shareholder
|
09057147 | 4 years |
| Director | Balaji Ramamurthy | 09350272 | 2 years |
| CS | Srividhya | <HIDDEN> | 8 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| REGENIX DENTAL CLINIC PRIVATE LIMITED |
Strike Off
|
1.0 L | 3 | Tamil Nadu |
| REGENIX SUPER SPECIALITY LABORATORIES PRIVATE LIMITED |
Active
|
1.2 Cr | 2 | Tamil Nadu |
| GFIN CAPITAL LIMITED |
Strike Off
|
5.0 L | 2 | Tamil Nadu |
| REGENIX HEALTH CARE LIMITED |
Strike Off
|
11.0 Cr | 2 | Tamil Nadu |
| REGENIX BIOSCIENCES LIMITED |
Active
|
14.4 Cr | 4 | Tamil Nadu |
| QUEEN PHARMACEUTICALS LIMITED |
Amalgamated
|
1.3 Cr | 2 | Tamil Nadu |
| MUR & MUR BIO SCIENCE AND HEALTH LIMITED |
Amalgamated
|
45.0 L | 2 | Tamil Nadu |
| BHARTI LIFE SCIENCES PRIVATE LIMITED. |
Amalgamated
|
1.6 Cr | 2 | Maharashtra |
| SUPERMED PHARMACY LIMITED |
Amalgamated
|
1.0 Cr | 2 | Tamil Nadu |
| PRIME PHARMACEUTICALS PRIVATE LIMITED |
Active
|
60.0 L | 1 | Maharashtra |
| AARTHI SCANS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Tamil Nadu |
| VISISHT HEALTH CARE CENTRE PRIVATE LIMITED |
Active
|
66.0 L | 1 | Tamil Nadu |
| ATM HEALTHCARE PRIVATE LIMITED |
Strike Off
|
6.2 L | 1 | Tamil Nadu |
| PRUDENT ORTHODONTIC SOLUTIONS PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Tamil Nadu |
| DAA CONSULTING PRIVATE LIMITED |
Active
|
10.9 L | 1 | Maharashtra |
| DAA TECHNOLOGIES PRIVATE LIMITED |
Active
|
3,000.0 | 1 | Tamil Nadu |
| D ARVIND & ASSOCIATES LLP |
Active
|
1.0 L | 1 | Tamil Nadu |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| REGENIX SUPER SPECIALITY LABORATORIES PRIVATE LIMITED | Tamil Nadu | 2011 | ₹ 1.2 Cr |
| REGENIX BIOSCIENCES LIMITED | Tamil Nadu | 2006 | ₹ 14.4 Cr |
The incorporation date of REGENIX DRUGS LIMITED is 10 May, 2007
The authorized share capital of REGENIX DRUGS LIMITED is INR ₹ 21.6 Cr.
The paid-up capital of REGENIX DRUGS LIMITED is INR ₹ 18.1 Cr.
The registered address of REGENIX DRUGS LIMITED is JAMAL SONU TERRACE, 42/1 LOGANATHAN NAGAR FIRST STREET, 100 FEET ROAD, CHOOLAIMEDU CHENNAI Tamil Nadu - 600094
The CIN number of REGENIX DRUGS LIMITED is U24232TN2007PLC063446.
Expand
Delete
Collapse
See
details
